EDITOR'S PICKS
DEEP DIVES
PE targets substance use care: 5 deals
Warburg Pincus, Frazier Healthcare Partners, Lee Equity and Sheridan are among the PE firms investing in the substance use care assets.
TECH WATCH
HEALTHCARE
THOUGHT LEADERSHIP
SPECIAL REPORTS
INDUSTRIAL/MANUFACTURING
ENERGY/POWER
VOX POPULI
Your value creation plan is not the problem – your operating model is
The firms that perform are not the ones with the most compelling theses. They are the ones with the most disciplined execution.
Healthcare M&A in 2026: Five rules smart sponsors are following
Dealmaking is on the upswing, but sponsors need to rethink their methods to get to the finish line, writes Matthew Brohm of Arnall Golden Gregory.
Why pharmacy remains a compelling mid-market play
Stability continues to present pharmacy as a compelling, high-resilience investment opportunity, write Mike Hess and Dawn Perez-Slavinski of Bass, Berry & Sims.
